GFR is a measure of how well your kidneys are filtering waste and excess fluid from your body. It is measured in milliliters per minute (mL/min). A normal GFR range is 90-120 mL/min for adults. A lower GFR can indicate that your kidneys are not functioning properly, and may be a sign of kidney disease. A GFR test is usually done as part of a regular physical exam, but it can also be done to monitor existing kidney problems.
Using a GFR calculator is simple. All you need to do is enter your age, gender, and creatinine level into the calculator. The calculator will then calculate your GFR and give you a result. It's important to note that the GFR calculator is not 100% accurate, and the results should be used as a guide only. Your doctor can help you interpret the results and come up with a treatment plan, if necessary.
Knowing your GFR is important for monitoring your kidney health. If your GFR is lower than normal, it could be a sign of kidney disease or other health problems. It can also help your doctor determine the best treatment plan for any existing kidney problems. Regular GFR tests can help you and your doctor monitor your kidney health and make sure any treatments are working.
Many hospitals and clinics have GFR calculators available for use. You can also find GFR calculators online. It's important to make sure you use a reputable calculator, as the results can vary significantly from one calculator to another. Some online calculators may even require you to enter additional information, such as your weight and height.
GFR is an important measure of kidney health, and can help you and your doctor monitor any existing kidney problems. Using a GFR calculator is the easiest way to calculate your GFR. You can find GFR calculators online or at your local hospital or clinic. It's important to make sure you use a reputable calculator and that you understand the results. Your doctor can help you interpret the results and come up with a treatment plan, if necessary.
1.
A single-cell analysis reveals a distinctive immunosuppressive tumor microenvironment in kidney cancer brain metastases.
2.
The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.
3.
Cancer diagnosis does not spur improvements to survivors' diets or eating habits
4.
According to a study by Amrita Hospital in Kochi, cancer mortality is rising among Indian women while declining for men.
5.
A garden can save your life
1.
Reshaping the Battlefield Through Tumor Microenvironment Modulation for Cancer Therapy
2.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
3.
Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors
4.
Cracking the Code of Subdural Hematomas: Modern Strategies for Optimal Care
5.
Imaging in Peritoneal Neoplasms: Diagnostic Advances and Multimodal Treatment Strategies
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
4.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation